			Home About us Contact

Infantile Hypertrophic Pyloric Stenosis (infantile + hypertrophic_pyloric_stenosis)

Distribution by Scientific Domains

Medical Sciences	75%

Selected Abstracts

Cystic fibrosis and infantile hypertrophic pyloric stenosis: Is there an association?

PEDIATRIC PULMONOLOGY, Issue 5 2002
Khalid S. Kakish MD
Abstract Cystic fibrosis (CF) is the most common lethal genetic disease among Caucasian populations. The generally accepted incidence of CF in the United States is 1 in 3,200 in the Caucasian population. Intestinal obstructions and atresias have been described among patients with CF. An association of CF with infantile hypertrophic pyloric stenosis (IHPS) has not been previously documented. A review in our clinic of 72 patients with CF revealed IHPS in two. The incidence of 2.7% is greater than the 0.3% incidence expected in the general population. This ninefold increase in IHPS in patients with CF suggests an association between the two and warrants further investigation. Pediatr Pulmonol. 2002; 33:404,405. © 2002 Wiley-Liss, Inc. [source]

Effects of Rikkunshi-to on infantile hypertrophic pyloric stenosis, refractory to atropine

PEDIATRICS INTERNATIONAL, Issue 4 2008
Noboru Oyachi
No abstract is available for this article. [source]

A Quantitative Study of the Neural Changes Underlying Pyloric Stenosis in Dogs

ANATOMIA, HISTOLOGIA, EMBRYOLOGIA, Issue 3 2002
R. M. Abel
Summary This study aimed to quantify the neural changes in congenital pyloric stenosis in dogs and to study the comparative anatomy between this condition in dogs and that in infantile hypertrophic pyloric stenosis. Eight specimens from the pylorus of dogs with pyloric stenosis and six control specimens were examined using conventional histology and immunohistochemistry for a range of neural antigens. The changes in the proportion of nerves immunoreactive for each antigen were quantified and analysed statistically. The morphology of the nerves in the diseased dogs was similar to that in controls. Only vasoactive intestinal peptide was reduced in expression in dogs (median proportion in control dogs 0.57, in diseased dogs 0.17; P = 0.065). This study demonstrates both morphological similarities and significant differences between closely related conditions in dogs, humans and other species. [source]